Weeks after Gilead Sciences Inc. got hit with a $200 million verdict in March for infringing Merck & Co.’s patents on a Hepatitis C medication, Fish & Richardson litigators turned the game around for their client.
Lead trial attorneys Juanita Brooks and Jonathan Singer, San Diego partners at the firm, which represented Gilead, persuaded U.S. District Judge Beth Labson Freeman to toss the verdict due to Merck’s “unclean hands.”